Product Information

ACAMPROSATE CALC DR 333 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.5859 per EA under NDC 68382056928. Its NADAC has been published 485 times since Aug 2, 2017.

FDA first approved this application on May 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACAMPROSATE CALC DR 333 MG TAB

acamprosate calcium
$0.5859per EA

Strength

333 mg/1

NDC

68382056928

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ACAMPROSATE CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA205995

FDA Approved

5/26/2017

TE Code

AB

On Market Since

6/1/2017

Price Statistics

The NADAC for ACAMPROSATE CALC DR 333 MG TAB has been published 485 times since Aug 2, 2017, and over the history we have for it it has declined 33.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5859 per EA
All-time high$0.9208 (Sep 13, 2017)
All-time low$0.2971 (Nov 20, 2024)
52-week high$0.6218
52-week low$0.5859
Median price$0.6297
Average price$0.6263
Largest weekly change+76.4% (Feb 12, 2025)
Weeks tracked485
Tracking sinceAug 2, 2017

Price History

1W

0.0%

1M

-0.5%

3M

-3.7%

6M

-1.6%

1Y

-2.2%

3Y

+16.3%

5Y

-25.0%

All

-33.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acamprosate calcium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACAMPROSATE CALC DR 333 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ACAMPROSATE CALC DR 333 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.5859 per EA (NDC 68382056928), effective Nov 11, 2026.

How has the price of ACAMPROSATE CALC DR 333 MG TAB changed over time?

Over the history we have for it, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has declined 33.0%. It has been tracked across 485 weekly CMS publications since Aug 2, 2017.

What are the highest and lowest recorded NADAC prices for ACAMPROSATE CALC DR 333 MG TAB?

Since Aug 2, 2017, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has ranged from a low of $0.2971 (Nov 20, 2024) to a high of $0.9208 (Sep 13, 2017), with a median of $0.6297 per EA.

Are there cheaper alternatives to ACAMPROSATE CALC DR 333 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of ACAMPROSATE CALC DR 333 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ACAMPROSATE CALC DR 333 MG TAB?

ACAMPROSATE CALC DR 333 MG TAB (NDC 68382056928) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.